Hemorrhoid. Unspecified hemorrhoids
Conditions
Interventions
Intervention 1: Intervention group: 500 mg Ruhemorrin (Ghaem Daro) capsule two times daily for 8 weeks. Intervention 2: Control group: Placebo contain maltodextrine, (500 mg), Ghaem darou company, two
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age above 18 years Having hemorrhoid according to internist diagnosis Willing to participate in the study
Exclusion criteria
Exclusion criteria: Pregnancy Lactation Having any type of cancer Having known renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemorrhoid severity. Timepoint: Baseline and at the end of the study. Method of measurement: hemorrhoids severity score (HSS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoodeh Razghei Jahromi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed